DK0934057T3 - Medicinske aerosolformuleringer med formoterol - Google Patents

Medicinske aerosolformuleringer med formoterol

Info

Publication number
DK0934057T3
DK0934057T3 DK97929756T DK97929756T DK0934057T3 DK 0934057 T3 DK0934057 T3 DK 0934057T3 DK 97929756 T DK97929756 T DK 97929756T DK 97929756 T DK97929756 T DK 97929756T DK 0934057 T3 DK0934057 T3 DK 0934057T3
Authority
DK
Denmark
Prior art keywords
formoterol
aerosol formulations
medicinal aerosol
medicinal
formulations
Prior art date
Application number
DK97929756T
Other languages
English (en)
Inventor
Martin J Oliver
Simon G Paling
Philip A Jinks
Sukhbinder K Jaiswal
Original Assignee
Minnesota Mining & Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10795182&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0934057(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Minnesota Mining & Mfg filed Critical Minnesota Mining & Mfg
Application granted granted Critical
Publication of DK0934057T3 publication Critical patent/DK0934057T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK97929756T 1996-06-11 1997-06-02 Medicinske aerosolformuleringer med formoterol DK0934057T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9612297.3A GB9612297D0 (en) 1996-06-11 1996-06-11 Medicinal aerosol formulations
PCT/US1997/009471 WO1997047286A1 (en) 1996-06-11 1997-06-02 Medicinal aerosol formulations of formoterol

Publications (1)

Publication Number Publication Date
DK0934057T3 true DK0934057T3 (da) 2005-01-24

Family

ID=10795182

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97929756T DK0934057T3 (da) 1996-06-11 1997-06-02 Medicinske aerosolformuleringer med formoterol

Country Status (16)

Country Link
EP (2) EP0934057B1 (da)
JP (1) JP5000793B2 (da)
AR (1) AR009231A1 (da)
AT (1) ATE275940T1 (da)
AU (1) AU726382B2 (da)
CA (1) CA2257841C (da)
DE (1) DE69730723T2 (da)
DK (1) DK0934057T3 (da)
ES (1) ES2229366T3 (da)
GB (1) GB9612297D0 (da)
ID (1) ID19520A (da)
NO (1) NO320403B1 (da)
NZ (1) NZ333202A (da)
PT (1) PT934057E (da)
WO (1) WO1997047286A1 (da)
ZA (1) ZA974546B (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054488A (en) * 1996-06-11 2000-04-25 3M Innovative Properties Company Medicinal aerosol formulations of formoterol
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
US6451285B2 (en) * 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
DE19847969A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
DK1121112T3 (da) * 1998-10-17 2002-09-16 Boehringer Ingelheim Pharma Lagringsdygtigt koncentrat af aktivt stof med formoterol
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
DZ3358A1 (fr) 2000-05-22 2001-11-29 Chiesi Farma Spa Formulations en solution pharmaceutiques pour inhalateurs-doseurs sous pression
SE0004750D0 (sv) * 2000-12-19 2000-12-19 Astrazeneca Ab Novel formulation
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
DK1273292T3 (da) 2001-07-02 2004-10-04 Chiesi Farma Spa Optimeret tobramycinformulering til aerosoldannelse
AR036358A1 (es) * 2001-08-28 2004-09-01 Schering Corp Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma
GB0207906D0 (en) 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
GB0207899D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and cielesonide aerosol formulations
PT1542904E (pt) * 2002-08-27 2008-03-24 Schering Corp Processo para produzir formulações para inaladores doseadores
JP2006527237A (ja) * 2003-06-13 2006-11-30 アルタナ　ファルマ　アクチエンゲゼルシャフト ホルモテロールと及びシクレソニドの組合せ物
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
WO2005041931A2 (en) * 2003-10-20 2005-05-12 Schering Corporation Pharmaceutical aerosol compositions
EP1925293A3 (en) * 2003-10-20 2010-01-13 Schering Corporation Pharmaceutical aerosol compositions
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
PL2077830T3 (pl) * 2006-10-17 2013-04-30 Lithera Inc Sposoby, kompozycje i formulacje do leczenia orbitopatii tarczycowej
TWI632926B (zh) 2009-05-29 2018-08-21 沛爾醫療股份有限公司 用於經由呼吸道遞送二或更多種活性藥劑的組成物、方法與系統
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
RS53514B1 (en) * 2009-10-02 2015-02-27 Chiesi Farmaceutici S.P.A. PHARMACEUTICAL AEROSOL FORMOTEROL FORMULATION AND BECLOMETHASONE DIPROPIONATE
EP2968152B2 (en) 2013-03-15 2022-06-22 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2050905A1 (en) * 1989-02-23 1990-08-24 George R. Felt Therapeutic aerosol formulations
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
DE69233150T2 (de) * 1991-06-10 2004-06-24 Schering Corp. Fluorchlorkohlenwasserstoffreie Aerosolformulierungen
ATE203900T1 (de) * 1991-06-10 2001-08-15 Schering Corp Fluorchlorkohlenwasserstofffreie aerosolformulierungen
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
EP0616525B1 (en) * 1991-12-12 1995-09-27 Glaxo Group Limited Pharmaceutical aerosol formulation
DE69232034T2 (de) * 1991-12-18 2002-06-06 Minnesota Mining And Mfg. Co., Saint Paul Aerosolzusammensetzungen für Arzneimittelsuspensionen
GB9207400D0 (en) * 1992-04-02 1992-05-13 Smithkline Beecham Plc Novel use
US5354934A (en) * 1993-02-04 1994-10-11 Amgen Inc. Pulmonary administration of erythropoietin
GB9425160D0 (en) * 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
GB9426252D0 (en) * 1994-12-24 1995-02-22 Glaxo Group Ltd Pharmaceutical composition

Also Published As

Publication number Publication date
DE69730723D1 (de) 2004-10-21
NO320403B1 (no) 2005-11-28
NZ333202A (en) 2000-06-23
WO1997047286A1 (en) 1997-12-18
ES2229366T3 (es) 2005-04-16
AU3373997A (en) 1998-01-07
ATE275940T1 (de) 2004-10-15
EP0934057B1 (en) 2004-09-15
NO985720L (no) 1999-02-11
DE69730723T2 (de) 2005-10-06
JP5000793B2 (ja) 2012-08-15
AU726382B2 (en) 2000-11-02
AR009231A1 (es) 2000-04-12
PT934057E (pt) 2004-12-31
JP2000513340A (ja) 2000-10-10
CA2257841A1 (en) 1997-12-18
ID19520A (id) 1998-07-16
EP1400239A1 (en) 2004-03-24
EP0934057A1 (en) 1999-08-11
CA2257841C (en) 2008-05-20
GB9612297D0 (en) 1996-08-14
NO985720D0 (no) 1998-12-07
ZA974546B (en) 1998-11-23

Similar Documents

Publication Publication Date Title
DK0934057T3 (da) Medicinske aerosolformuleringer med formoterol
ATE236617T1 (de) Aerosol-arzneiformulierungen
IT1293803B1 (it) Formulazioni di aerosol medicinali
DK67795A (da) Insulinanalog-formuleringer
BR9500784A (pt) Composto e formulação farmacêutica
BR9504060A (pt) Composto e formulação farmacêutica
DE69723202D1 (de) Inhalatoren
DK1073417T3 (da) Farmaceutisk aerosolformulering
ID23299A (id) Formulasi-formulasi farmasi
NO954486D0 (no) Farmasöytiske formuleringsgrunnlag
PT932397E (pt) Formulacoes em aerossol medicinais compreendendo budesonida
BR9509688A (pt) Composto e composição farmacêutica
ID16781A (id) Formulasi-formulasi farmasi
ITMI941169A0 (it) Formulazioni farmaceutiche
ATE298576T1 (de) Arzneizubereitungen
ID18698A (id) Komposisi farmasi
ATE237309T1 (de) Arzneizubereitungen
FI951155A0 (fi) Farmaseuttinen valmiste
BR9505130A (pt) Composto e composiçao farmacêutica
SE9404467D0 (sv) Drug formulations
SE9404469D0 (sv) Aerosol formulations
SE9600141D0 (sv) Pharmaceutical formulation
SE9404195D0 (sv) New pharmaceutical formulation
BR1100838A (pt) Composto e composição farmacêutica
SE9703737D0 (sv) Pharmaceutical composition and use